Benralizumab Reduces Flare-Ups

This is a UK news story, published by Gizmodo.

UK news

For more UK news, you can click here:

more UK news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Gizmodo news

For more news from Gizmodo, you can click here:

more news from Gizmodo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

taking benralizumab

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest antibody drug news, asthma attacks news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

benralizumab

Gizmodo

•

Scientists Uncover 'Game-Changing' Therapy for Asthma Attacks

Summary

Nutrition label

87% Informative

Scientists in the UK , Australia , and Sweden conducted the double-blinded, controlled, and randomized phase II trial, which aimed to test the potential of benralizumab in treating a particular type of asthma or COPD attack.

People who took the drug were significantly less likely to need further treatment or to end up in a hospital.

The findings could pave the way for the already approved drug to become the first new drug to treat these potentially life-threatening attacks in 50 years .

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech

not hateful